{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:04:59Z","timestamp":1772107499740,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.jbspin.2004.07.006","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:24:36Z","timestamp":1095791076000},"page":"481-485","source":"Crossref","is-referenced-by-count":50,"title":["Current management of gout in patients unresponsive or allergic to allopurinol"],"prefix":"10.1016","volume":"71","author":[{"given":"Thomas","family":"Bardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2004.07.006_bib1","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib2","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"Gout N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.07.006_bib3","series-title":"L\u2019Actualit\u00e9 Rhumatologique 1996","first-page":"328","article-title":"Les manifestations d\u2019intol\u00e9rance \u00e0 l\u2019allopurinol en 1996","author":"Liot\u00e9","year":"1996"},{"key":"10.1016\/j.jbspin.2004.07.006_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000052122","article-title":"Guillain-Barre syndrome and allopurinol-induced hypersensitivity","volume":"45","author":"Benito-Leon","year":"2001","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0002-9343(84)90743-5","article-title":"Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency","volume":"76","author":"Hande","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2004.07.006_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.60.10.981","article-title":"Relation between adverse events associated with allopurinol and renal function in patients with gout","volume":"60","author":"Vazquez-Mellado","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2004.07.006_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00124743-199904000-00003","article-title":"Treatment of chronic gout in patients with renal function impairment. An open, randomized, actively controlled study","volume":"5","author":"Perez-Ruiz","year":"1999","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(04)16000-5","article-title":"Alcohol intake and risk of incident gout in men: a prospective study","volume":"363","author":"Choi","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2004.07.006_bib9","first-page":"1350","article-title":"Gout, diet, and the insulin resistance syndrome","volume":"29","author":"Fam","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa035700","article-title":"Purine-rich foods, dairy and protein intake, and the risk of gout in men","volume":"350","author":"Choi","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbspin.2004.07.006_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.62.6.497","article-title":"Fenofibrate and losartan","volume":"62","author":"Bardin","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2004.07.006_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-002-0658-1","article-title":"Long-term remission from gout associated with fenofibrate therapy","volume":"22","author":"Hepburn","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1054-3589(08)60098-8","article-title":"Uricosuric drugs, with special reference to probenecid and sulfinpyrazone","volume":"4","author":"Gutman","year":"1966","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib14","series-title":"La goutte","author":"Ryckewaert","year":"1962"},{"key":"10.1016\/j.jbspin.2004.07.006_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00005792-196012000-00001","article-title":"The kidney in gout","volume":"39","author":"Talbott","year":"1960","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2004.07.006_bib16","series-title":"Goodman and Gilman\u2019s the pharmacological basis of therapeutics. 9th ed","article-title":"Analgesic-antipyretic and antiinflammatory agents, and drugs employed in the treatment of gout","author":"Insel","year":"1996"},{"key":"10.1016\/j.jbspin.2004.07.006_bib17","first-page":"2873","article-title":"Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis","volume":"27","author":"Harris","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/ard.57.9.545","article-title":"Efficacy of allopurinol and benzbromarone for the control of hyperuricaemia. A pathogenic approach to the treatment of primary chronic gout","volume":"57","author":"Perez-Ruiz","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2004.07.006_bib19","first-page":"437","article-title":"The pharmacology of hypouricemic effect of benzbromarone","volume":"2","author":"Sinclair","year":"1975","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib20","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/978-1-4684-3285-5_49","article-title":"The pharmacology of the hypouricemic effect of benzbromarone","volume":"76B","author":"Fox","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1440-1746.2002.02692.x","article-title":"Fulminant hepatic failure associated with benzbromarone treatment: a case report","volume":"17","author":"Arai","year":"2002","journal-title":"J. Gastroenterol Hepatol."},{"key":"10.1016\/j.jbspin.2004.07.006_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7326\/0003-4819-85-3-333","article-title":"Allergic reaction to allopurinol with cross-reactivity to oxypurinol","volume":"85","author":"Lockard","year":"1976","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jbspin.2004.07.006_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(92)90236-5","article-title":"Desensitization to allopurinol in patients with gout and cutaneous reactions","volume":"93","author":"Fam","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jbspin.2004.07.006_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7","article-title":"Efficacy and safety of desensitization to allopurinol following cutaneous reactions","volume":"44","author":"Fam","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2004.07.006_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard.46.8.646","article-title":"Desensitisation to allopurinol: a cautionary tale","volume":"46","author":"Unsworth","year":"1987","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jbspin.2004.07.006_bib26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1345\/aph.19043","article-title":"Desensitization to allopurinol in a patient with previous failed desensitization","volume":"33","author":"Tanna","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jbspin.2004.07.006_bib27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jbspin.2004.07.006_bib28","first-page":"392","article-title":"Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases","volume":"62","author":"Rozenberg","year":"1995","journal-title":"Rev. Rhum. Engl. Ed"},{"key":"10.1016\/j.jbspin.2004.07.006_bib29","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","article-title":"Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies","volume":"11","author":"Pui","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.jbspin.2004.07.006_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CLM.2003.n.003","article-title":"Recombinant urate oxidase for prevention of hyperuricemia and tumor lysis syndrome in lymphoid malignancies","volume":"3","author":"Ribeiro","year":"2003","journal-title":"Clin. Lymphoma."},{"key":"10.1016\/j.jbspin.2004.07.006_bib31","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1345\/aph.1C336","article-title":"Rasburicase for the treatment and prevention of hyperuricemia","volume":"37","author":"Yim","year":"2003","journal-title":"Ann. Pharmacother"},{"key":"10.1016\/j.jbspin.2004.07.006_bib32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ndt\/18.3.603","article-title":"Long-term efficacy of hyperuricaemia treatment in renal transplant patients","volume":"18","author":"Perez-Ruiz","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jbspin.2004.07.006_bib33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/ndt\/9.5.548","article-title":"Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study","volume":"9","author":"Zurcher","year":"1994","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jbspin.2004.07.006_bib34","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/ndt\/gfg341","article-title":"Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients","volume":"18","author":"Chanard","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jbspin.2004.07.006_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(00)04055-1","article-title":"Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study","volume":"357","author":"Schlitt","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2004.07.006_bib36","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/00007890-199710150-00027","article-title":"Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout","volume":"64","author":"Jacobs","year":"1997","journal-title":"Transplantation"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04001484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X04001484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T19:24:59Z","timestamp":1549221899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X04001484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1297319X04001484"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2004.07.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}